In addition, in this research, full‐length COL6 was also found to be upregulated in breast cancer tissue and associated with the migration of breast cancer cells through NG2–EGFR crosstalk and MAPK signal transduction pathways, proving that COL6 may be a new trigger for breast cancer specificity. The gene discussed is EGFR; the disease is breast carcinoma.